Enhancement of Zika Infection by Dengue Virus-Specific Antibody Is Associated With Low Levels of Antiviral Factors

J Infect Dis. 2017 Sep 1;216(5):612-614. doi: 10.1093/infdis/jix344.

Authors

Linda Hueston¹, Ruben Ramirez², Suresh Mahalingam³

Affiliations

¹ Arbovirus Emerging Disease Unit, Centre for Infectious Diseases and Microbiology Laboratory Services and The Institute for Clinical Pathology and Medical Research (CIDMLS-ICPMR), Westmead Hospital,New South Wales.
² Faculty of Applied Science, University of Canberra, Australian Capital Territory.
³ Emerging Viruses and Inflammation Research Group, Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.

PMID: 28931226
DOI: 10.1093/infdis/jix344

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antiviral Agents
Brazil
Dengue Virus*
Humans
Zika Virus
Zika Virus Infection*

Substances

Antiviral Agents